The vast majority of the nearly 6 million coronavirus diagnoses in the United States likely were not contagious, according to the New York Times.Despite continued widespread COVID-19 panic, which includes many virus-related restrictions, up to 90% of individuals who have tested positive for COVID-19 potentially carried such "insignificant" amounts of the virus that they were…
Pierre-Emerick Aubameyang of Arsenal celebrates (Getty). Arsenal reached a record 21st FA Cup final as Pierre-Emerick Aubameyang's double clinched a shock 2-0 win over holders Manchester City at Wembley on Saturday.Gunners boss Mikel Arteta out-witted City manager Pep Guardiola with an astute counter-attacking scheme and Aubameyang struck in each half as Arsenal executed the plan…
Passengers used to paying R11 for a trip by taxi from the sprawling township of Alexandra to Africa’s richest square mile, Sandton, will have to cough up R30 from next week NEWSPassengers used to paying R11 for a trip by taxi from the sprawling township of Alexandra to Africa’s richest square mile, Sandton, will have…
By Jessica Hamzelou The Ishihara colour perception testB Christopher / Alamy A shock of electricity to the temples can be a powerful, last-resort treatment for some people who have mental health conditions that don’t respond to other treatments. But it can have surprising side effects – it seems to have improved the colour vision of…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment